Skip to Main Content

News

Pretzel Therapeutics Launches With $72.5 Million Series A Financing to Pioneer Mitochondrial Therapies

September 12, 2022

Press
Releases

Pretzel: modulating the mitochondrial genome

Pretzel Gets $72.5M for Gene Editing & Small Molecules Against Mitochondrial Targets

Timmerman Report

Pretzel Therapeutics launches to advance mitochondria-based therapies

Chemical & Engineering News

Waltham biotech Pretzel Therapeutics launches with $72.5m

Freshly baked: Pretzel Therapeutics takes out the oven mitts to drug diseases in the powerhouse of the cell

Mitochondrial drugs, with a twist: Pretzel Therapeutics launches with $72.5M in funding

In the News